Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/17/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSZSE
Market Capitalization15,947 mln
Float703 mln
EPS
0.04
Overpriced
P / E
419
Bubble territory
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.45
Borderline
Relative Strength
65
/ 100
Outperforming
Debt / Equity
0.87
Moderate leverage
Business Description
Founded in 1990 and headquartered in Tonghua, China, Tonghua Golden-Horse Pharmaceutical Industry develops, manufactures, and sells a broad range of medical products across numerous therapeutic areas, including cancer treatment, heart and blood vessel health, digestive care, bone and muscle recovery, and women's and children's health. The company offers both traditional Chinese medicines and modern pharmaceutical treatments, with well-known products such as Xiaojin Pills, Bear Bile Powder, and Wenweishu Tablets used to address conditions ranging from inflammatory diseases to bone injuries. It also produces live bacteria preparations designed to treat digestive disorders such as enteritis and diarrhea in both adults and children.
